Past, present, and future of insulin pump therapy: better shot at diabetes control.

The Mount Sinai Journal of Medicine, New York
Jennifer L Sherr, William V Tamborlane

Abstract

With the advent of continuous subcutaneous insulin infusion therapy and the findings of the Diabetes Control and Complications Trial, the management of type 1 diabetes has changed drastically. Over the past 30 years since its development, the effectiveness of continuous subcutaneous insulin infusion has been assessed in comparison with other modes of intensive treatment. Additionally, improvements in pump delivery systems have been made. Here, the findings of the studies on pump therapy are reviewed. Selection criteria of patients for pump use and how to initiate pump therapy are presented. Finally, newer findings on continuous glucose sensors are discussed as the next era of pump therapy continues to focus on the goal of developing an artificial pancreas.

References

Jan 28, 1978·British Medical Journal·J C PickupK G Alberti
May 28, 1987·The New England Journal of Medicine·S A AmielR S Sherwin
May 1, 1983·Diabetologia·T LauritzenC Binder
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Dec 18, 2001·The Journal of Pediatrics·N H WhiteUNKNOWN Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Gro
Mar 29, 2003·Diabetes Care·Jill Weissberg-BenchellRoopa Seshadri
Dec 6, 2003·The Journal of Pediatrics·Steven M WilliSharon Schwarz
Sep 3, 2004·The Journal of Pediatrics·Linda A DiMeglioErica A Eugster
Oct 27, 2004·Diabetes Care·Walid KaplanRubina A Heptulla
Dec 25, 2004·Diabetes/metabolism Research and Reviews·Riccardo SchiaffiniAntonino Crinó
Jan 8, 2005·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Susan Sullivan-BolyaiMargaret Grey
Mar 2, 2005·Diabetes Technology & Therapeutics·Michael J TanseyUNKNOWN Diabetes Research in Children Network (DirecNet) Study Group
May 6, 2005·Treatments in Endocrinology·William V TamborlaneJoAnn H Ahern
Oct 18, 2005·The Journal of Pediatrics·Eva TsalikianUNKNOWN Diabetes Research In Children Network Direcnet Study Group
Dec 24, 2005·Diabetes Care·Michael J TanseyUNKNOWN Diabetes Research in Children Network (DirecNet) Study Group

❮ Previous
Next ❯

Citations

Jul 1, 2010·Experimental Diabetes Research·Vasiliki Valla
Oct 12, 2013·Indian Journal of Pediatrics·Vandana Jain
May 12, 2012·Endocrinology and Metabolism Clinics of North America·William V Tamborlane, Kristin A Sikes
Feb 4, 2012·Pediatric Annals·Jennifer L Sherr, Stuart A Weinzimer
May 17, 2015·Journal of Pediatric Psychology·Jadienne H LordSarah S Jaser
Apr 8, 2016·Wiener klinische Wochenschrift·Marietta StadlerMartin Bischof
Apr 11, 2009·The Diabetes Educator·Gary ScheinerKaren Green
Feb 6, 2018·Current Diabetes Reports·Katia M PerezSarah S Jaser
Oct 27, 2009·Current Opinion in Organ Transplantation·Christopher N Mayhew, James M Wells
Mar 17, 2019·Diagnostics·Natalie Allen, Anshu Gupta
Apr 14, 2019·Wiener klinische Wochenschrift·Ingrid Schütz-FuhrmannRaimund Weitgasser
Aug 31, 2012·Nursing·Lucille Hughes
May 18, 2020·Advanced Drug Delivery Reviews·Nikolaj Kofoed MandsbergSarvesh Kumar Srivastava
Jun 8, 2021·AACE Clinical Case Reports·Zulekha AtifStanislaw P Klek
Jul 1, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.